Your session is about to expire
Esomeprazole vs Omeprazole
Introduction
For patients with gastroesophageal reflux disease (GERD) or other types of acid-related disorders, certain drugs that alter the amount of stomach acid production can help in managing symptoms. Esomeprazole and Omeprazole are two such drugs often prescribed for these conditions. They each impact different aspects of gastric acid secretion, but both have significant effects in reducing stomach acidity.
Esomeprazole is a proton pump inhibitor (PPI), which effectively lowers levels of stomach acids by binding to H+/K+ ATPase enzymes found within the lining of your stomach's walls. On the other hand, Omeprazole also belongs to the PPI class and works similarly by suppressing gastric acid secretions. However, it operates at a slightly different metabolic level than esomeprazole leading to subtle differences in their pharmacological profiles.
Esomeprazole vs Omeprazole Side By Side
| Attribute | Nexium | Prilosec |
|---|---|---|
| Brand Name | Nexium | Prilosec |
| Contraindications | Should not be taken with HIV protease inhibitors such as atazanavir. Prolonged use may result in vitamin B12 deficiency. | Should not be taken with HIV protease inhibitors such as atazanavir. Prolonged use may result in vitamin B12 deficiency. |
| Cost | Approximately $0.17 to $2 per day for generic versions | As low as $.10/day up to about $.90 /day for generic versions |
| Generic Name | Esomeprazole | Omeprazole |
| Most Serious Side Effect | Signs of kidney problems, symptoms of lupus, symptoms related to vitamin B-12 deficiency, unusual muscle weakness, severe dizziness, irregular heartbeat, signs of an allergic reaction. | Allergic reactions, severe skin reactions, new onset of lupus symptoms, kidney problems, low magnesium levels, unusual bleeding or bruising. |
| Severe Drug Interactions | HIV protease inhibitors such as atazanavir | HIV protease inhibitors such as atazanavir |
| Typical Dose | 20–40 mg/day | 20 mg per day, may be increased to 40 mg per day |
What is Esomeprazole?
Esomeprazole (the generic name for Nexium) is a proton pump inhibitor (PPI), which marked significant progress from the previous class of gastric acid inhibitors known as H2 receptor blockers. Esomeprazole was first approved by the FDA in 2001. Nexium works by reducing stomach acid production, effectively "trapping" it in the stomach lining for longer than usual. It is prescribed primarily for treating different forms of gastroesophageal reflux disease (GERD). Nexium has a selective influence on proton pumps with only minor effects on other bodily enzymes, which results in it having fewer side effects than other medicines that have stronger impacts on these other body functions.
On the other hand, Omeprazole (the generic name for Prilosec) also belongs to the same class of drugs - PPIs and was approved by the FDA much earlier than Esomeprazole; specifically, in 1989. Both drugs work similarly to decrease stomach acid but there are slight differences between them regarding their potency and cost-effectiveness.
What conditions is Esomeprazole approved to treat?
Esomeprazole is effective for the treatment of a variety of gastrointestinal conditions:
- Gastroesophageal reflux disease (GERD)
- Healing and maintenance of erosive esophagitis
- Risk reduction of gastric ulcers associated with continuous NSAID use
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence, in combination with other medications
How does Esomeprazole help with these illnesses?
Esomeprazole works to manage gastroesophageal reflux disease (GERD) and other similar conditions by reducing the amount of acid produced in the stomach. It does this by inhibiting a type of cell within your stomach known as a proton pump, which is responsible for secreting hydrochloric acid. Hydrochloric acid plays an essential role in digestion but excessive amounts can lead to heartburn, GERD, and other digestive issues. Thus, it's understood that people with these conditions have relatively higher levels of gastric acid production. Therefore, by decreasing the production of hydrochloric acid through blocking proton pumps, esomeprazole can help alleviate symptoms associated with excess stomach acidity and aid individuals in managing their condition more effectively.
What is Omeprazole?
Omeprazole, marketed under the brand name Prilosec and others, is a proton pump inhibitor (PPI) that decreases the amount of acid produced in the stomach. This drug was first approved by FDA in 1989. It works by inhibiting a mechanism known as H+/K+ ATPase enzyme system found on gastric parietal cells - essentially reducing their ability to produce stomach acid.
Unlike esomeprazole, omeprazole is not specifically activated which means it can be taken at any time during the day with consistent results. Its mode of action generally leads to fewer side effects compared to other medications for acid reflux such as antacids or H2 blockers. The most common side effects include headache, nausea and diarrhea but these are usually mild and transient. Omeprazole's effect on decreasing stomach acidity can be beneficial for treating conditions like gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome.
What conditions is Omeprazole approved to treat?
Omeprazole is an FDA-approved medication that is most commonly used for the treatment of conditions caused by excess stomach acid. It has been deemed effective for:
- Gastroesophageal reflux disease (GERD)
- Erosive esophagitis
- Stomach ulcers
- Prevention and maintenance of gastric and duodenal ulcers induced by NSAIDs
How does Omeprazole help with these illnesses?
Omeprazole is a proton pump inhibitor that works by decreasing the amount of acid produced in the stomach. It plays an important role in treating conditions caused by excessive stomach acid, like gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Omeprazole achieves this by blocking the enzyme system found on stomach lining cells that secretes gastric acid, thereby reducing its production and secretion into the gastric lumen. Its action also aids in healing erosive esophagitis damage to your esophagus caused by stomach acid. Although it has similar effects as Esomeprazole, omeprazole may be preferred for patients who respond better to its specific pharmacological profile or find it more cost-effective since it's available as a generic.
How effective are both Esomeprazole and Omeprazole?
Both esomeprazole (Nexium) and omeprazole (Prilosec) have proven to be highly effective in treating conditions related to gastric acid hypersecretion, such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. They are both proton pump inhibitors (PPIs), meaning they work by reducing the production of stomach acid.
Esomeprazole is the newer of the two medications, having been approved by the FDA in 2001, nearly a decade after omeprazole's approval in 1989. Despite this difference in timelines, both drugs have amassed an extensive history of usage with positive patient outcomes and well-characterized safety profiles.
Clinical trials comparing these two PPIs consistently demonstrate that esomeprazole tends to provide superior control of gastric acidity when compared directly with equivalent doses of omeprazole. A meta-analysis published in 2014 concluded that patients treated with esomeprazole had significantly higher healing rates for erosive GERD than those treated with other PPIs including omeprazole.
Despite this superiority at controlling gastric acidity levels on a population level, it should be noted that individual response can vary greatly due to factors like genetic variability in drug metabolism or differences in symptom severity. Therefore while some patients may experience better symptom relief from esomeprazole than from omeprazolam; others may find their symptoms equally well-controlled by either medication.
In terms of side effects profile comparison between these two drugs; Esomeprozole seems safer according to certain studies because it provides more potent acid suppression which reduces the risk for bleeding especially among high-risk individuals who consume aspirin regularly. For example one study published on Journal Watch General Medicine showed evidence suggesting that among patients at high cardiovascular risk taking aspirin-based antiplatelet therapy for secondary prevention regular use Esomperozole was associated with fewer upper GI events but slightly increased risks for pneumonia and fracture.
Related trials for esomeprazole and omeprazole
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Esomeprazole typically prescribed?
Oral dosages of Esomeprazole range from 20–40 mg/day, ideally for treating gastroesophageal reflux disease and other conditions involving excessive stomach acid. For most adults, a dose of 20 mg/day is typically sufficient. Children aged 1 to 11 years may be started on doses between 10-20 mg/day depending on the specific condition being treated. In either population, dosage can be increased after a few weeks if there is no response. The maximum dosage that should not be exceeded in any case is 40 mg/day.
On the other hand, Omeprazole oral dosages also range from 20–40 mg per day with most people finding relief at a daily dose of just 20mg for duodenal ulcers or gastroesophageal reflux disease (GERD). Pediatric patients over one year old may start at lower doses around 10-20mg depending on body weight and condition severity. If no improvement is seen within several weeks, the dose may increase up to the maximum recommended daily dose which varies by indication but generally should not exceed more than twice the initial therapeutic amount (i.e., up to max ~80mg for some severe cases under medical supervision).
At what dose is Omeprazole typically prescribed?
Omeprazole treatment typically begins at a dosage of 20 mg per day, taken orally before meals. If needed, the dose may be increased to 40 mg per day, which is usually divided into two doses and spaced approximately 12 hours apart. The maximum recommended dose for Omeprazole is generally around 80 mg per day, which can be divided into several smaller doses throughout the day if necessary. This higher dosage might be considered if there is no noticeable improvement in symptoms after a few weeks on the initial dosing regimen.
What are the most common side effects for Esomeprazole?
Common side effects of esomeprazole can include:
- Headache
- Nausea, gas, upset stomach
- Diarrhea or constipation
- Dry mouth or an unusual taste in the mouth
- Drowsiness (somnolence)
- Asthenia (general weakness and fatigue)
- Skin rash or itching
Omeprazole also has similar common side effects which include:
- Headache
- Abdominal pain, nausea, diarrhea, vomiting and flatulence (gas)
- Upper respiratory tract infection in children
- Fever in children A few rare but more serious side effects could occur with both drugs. If you experience any severe symptoms such as chest pain, fast heartbeat or feeling lightheaded/fainting it's important to seek immediate medical attention.
Are there any potential serious side effects for Esomeprazole?
While rare, severe side effects can occur with both esomeprazole and omeprazole. If you note any of these symptoms, seek medical attention immediately:
- Signs of kidney problems such as change in the amount of urine
- Symptoms of lupus like rash on nose and cheeks, new or worsening joint pain
- Symptoms related to vitamin B-12 deficiency: unusual weakness, sore tongue, numbness or tingling of the hands/feet
- Unusual muscle weakness
- Severe dizziness, irregular heartbeat
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat.
In very rare cases signs might appear indicating a possible serious intestinal condition (Clostridium difficile-associated diarrhea): persistent diarrhea abdominal or stomach pain/cramping fever blood/mucus in stool.
Moreover be aware that prolonged use may increase the risk for bone fractures especially if dosage is high or used for a year or longer. Therefore it's important to take this medication exactly as prescribed by your health care provider.
What are the most common side effects for Omeprazole?
Omeprazole, while generally well-tolerated, can cause a range of side effects such as:
- A dry mouth or an unusual sensation in the mouth
- Stomach discomfort including gas, nausea and vomiting
- Constipation or diarrhea
- Headache or dizziness
- Sleep problems like insomnia
- Muscle weakness or joint pain
Although not common, some people may experience more serious symptoms like rapid heart rate, unexplained weight loss, persistent vomiting/nausea and extreme fatigue. It's essential to communicate with your healthcare provider if you notice any adverse reactions after starting Omeprazole.
Are there any potential serious side effects for Omeprazole?
While Omeprazole is generally well-tolerated, there are certain serious side effects that can occur in rare circumstances. Some of the more severe issues may include:
- Indications of an allergic reaction, such as hives, itching or a fever; swollen glands; difficulty breathing or swelling in your face or throat
- Severe skin reactions including blisters and peeling
- New onset of lupus symptoms like joint pain and rash on cheeks/nose worsened by sun exposure
- Kidney problems manifesting as changes in urination frequency, blood presence in urine or sudden weight gain from fluid retention
- Low magnesium levels leading to seizures (convulsions), irregular heartbeats, jitteriness, muscle cramps/spasms/weakness
- Unusual bleeding or bruising
Should you experience any of these side effects while using Omeprazole it's crucial to contact a health professional immediately.
Contraindications for Esomeprazole and Omeprazole?
Both esomeprazole and omeprazole, along with most other proton pump inhibitors (PPIs), may increase the risk of certain side effects in some people. If you notice persistent diarrhea, bone fractures or muscle spasms, please seek immediate medical attention.
Neither esomeprazole nor omeprazole should be taken if you are taking or have been taking HIV protease inhibitors such as atazanavir. Always tell your physician which medications you are taking; these drugs will need a period to clear from your system before starting treatment with esomeprazole or omeprazole to prevent dangerous interactions.
Furthermore, prolonged use of PPIs such as esomeprazole and omeprazole can result in vitamin B12 deficiency. If symptoms such as fatigue, nerve damage, memory issues persist, notify your healthcare provider promptly.
How much do Esomeprazole and Omeprazole cost?
For the brand name versions of these drugs:
- The price for 30 capsules of Nexium (Esomeprazole, 40 mg) averages around $240, which works out to about $8/day.
- The price for 30 tablets of Prilosec (Omeprazole, 20 mg) is approximately $170, working out to roughly $5.67/day.
Thus, if you are in the higher dosage range for Esomeprazole (i.e., up to 40 mg/day), then brand-name Omeprazole is less expensive on a per-day treatment basis. However, cost should not be your primary consideration when deciding between these two medications; effectiveness and side effects are also essential factors.
As for generic versions of both drugs:
- Generic esomeprazole costs significantly less at approximately $0.17 to $2 per day depending on dose and pack size.
- Generic omeprazole comes with an even lower cost ranging from as low as $.10/day up to about $.90 /day depending upon where it's purchased and the quantity bought at once.
Popularity of Esomeprazole and Omeprazole
Esomeprazole, offered in generic form and under brand names such as Nexium, was estimated to have been prescribed to about 15.8 million people in the US in 2020. Esomeprazole accounted for just over 30% of proton pump inhibitor prescriptions in the US. However, it appears to be the most-common “S-isomer” proton pump inhibitor (a specific type of compound that inhibits gastric acid secretion). The use of esomeprazole has been generally increasing since its introduction.
Omeprazole, including brand versions such as Prilosec, was prescribed to roughly 20.1 million people in the USA in 2020. In the US, omeprazole accounts for approximately 40% of proton pump inhibitor prescriptions overall and ranks among some of topmost used drugs by prescription count given its efficacy and safety profile along with affordability due to availability as a generic medication for quite a long time now. The prevalence of omeprazole has remained fairly steady over the last decade.
Conclusion
Both esomeprazole and omeprazole have a long-standing usage in patients with gastroesophageal reflux disease (GERD), peptic ulcer disease, and other acid-related disorders. They belong to a class of drugs known as proton pump inhibitors (PPIs) that decrease the amount of acid produced by the stomach, thereby providing relief from heartburn and promoting healing of ulcers.
Esomeprazole is essentially an improved version or "isomer" of omeprazole. It has been shown in some studies to be more effective at reducing gastric acidity than omeprazole, although both are generally well tolerated.
While these two medications share similar mechanisms of action, they may not necessarily be interchangeable due to differences in their pharmacokinetics - how they move through the body. Esomeprazole tends to remain active longer than omeprazole because it's metabolized slower by the body.
Both drugs are available in generic form which offers significant cost savings for patients who pay out-of-pocket; however, despite being part of the same drug class, there can still be noticeable price differences between them based on factors such as brand versus generic status and dosage strength.
The side effects profiles for esomeprazole and omeprazole are also quite similar - common ones include headache, nausea, diarrhea, abdominal pain and dizziness. Both require monitoring when starting treatment mainly due to potential interactions with other medicines or conditions making one medication preferable over another depending on individual case scenarios. As always consult your healthcare professional if you experience persistent adverse effects while taking either medication.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Caro, J. (2001, July). Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/s0149-2918(01)80087-4
- Scott, L. J., Dunn, C. J., Mallarkey, G., & Sharpe, M. (2002). Esomeprazole. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200262100-00006
- Robinson, M., & Horn, J. (2003). Clinical Pharmacology of Proton Pump Inhibitors. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200363240-00004
- Huang, J.-Q., & Hunt, R. H. (2001, June). Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician. Best Practice & Research Clinical Gastroenterology. Elsevier BV.http://doi.org/10.1053/bega.2001.0184
- Kahrilas, P. J., Falk, G. W., Johnson, D. A., Schmitt, C., Collins, D. W., Whipple, J., … FOR THE ESOMEPRAZOLE STUDY INVESTIGATORS. (2000, October). Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Alimentary Pharmacology & Therapeutics. Wiley.http://doi.org/10.1046/j.1365-2036.2000.00856.x
- Youssef, N. N., Tron, E., Tolia, V., Hamer-Maansson, J. E., Lundborg, P., & Illueca, M. (2014, November 1). Single-dose pharmacokinetic properties of esomeprazole in children aged 1 – 11 years with endoscopically proven GERD: a randomized, open-label study. Int. Journal of Clinical Pharmacology and Therapeutics. Dustri-Verlgag Dr. Karl Feistle.http://doi.org/10.5414/cp201971
- Kita, T., Sakaeda, T., Aoyama, N., Sakai, T., Kawahara, Y., Kasuga, M., & Okumura, K. (2002). Optimal Dose of Omeprazole for CYP2C19 Extensive Metabolizers in Anti-Helicobacter pylori Therapy: Pharmacokinetic Considerations. Biological and Pharmaceutical Bulletin. Pharmaceutical Society of Japan.http://doi.org/10.1248/bpb.25.923
- Reilly, J. P. (1999, December 1). Safety profile of the proton-pump inhibitors. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.1093/ajhp/56.suppl_4.s11
- Kamann, S., Bauer, C., Fackler, I., & Przybilla, B. (2006, November). Anaphylaxie auf Omeprazol. Der Hautarzt. Springer Science and Business Media LLC.http://doi.org/10.1007/s00105-005-1076-5
- Andersson, T., RÖhss, K., Bredberg, E., & Hassan‐Alin, M. (2001, October 2). Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole. Alimentary Pharmacology & Therapeutics. Wiley.http://doi.org/10.1046/j.1365-2036.2001.01087.x